Literature DB >> 11128349

Remnant-like particle cholesterol, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients.

A Taniguchi1, M Fukushima, M Sakai, K Miwa, T Makita, I Nagata, S Nagasaka, K Doi, T Okumura, A Fukuda, H Kishimoto, T Fukuda, S Nakaishi, K Tokuyama, Y Nakai.   

Abstract

OBJECTIVE: The aim of the study was to investigate the relationships between remnant-like particle (RLP) cholesterol, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients. RESEARCH DESIGN AND METHODS: A total of 86 nonobese Japanese type 2 diabetic patients (72 men and 14 women, aged 40-83 years, BMI 20.1-26.6 kg/m2) were studied. BMI, HbA1c levels, and fasting concentrations of plasma glucose, serum lipids (RLP cholesterol, total cholesterol, HDL cholesterol, and triglycerides), and serum insulin were measured. Insulin resistance was estimated by the homeostasis model assessment (HOMA-IR). The subjects were divided into two groups according to the value of HOMA-IR. Values >2.5 were indicative of the insulin-resistant state, and values <2.5 were indicative of the insulin-sensitive state.
RESULTS: The insulin-resistant group had significantly higher RLP cholesterol and triglyceride levels and lower HDL cholesterol levels compared with the insulin-sensitive group. Univariate regression analysis showed that insulin resistance was positively correlated with BMI (r = 0.254, P = 0.019), HbA1c levels (r = 0.278, P = 0.011), RLP cholesterol levels (r = 0.315, P = 0.004), and triglyceride levels (r = 0.332, P = 0.002) and was negatively correlated with HDL cholesterol levels (r = -0.301, P = 0.006) in our diabetic patients. Multiple regression analysis showed that insulin resistance was independently associated with serum triglyceride levels, which explained 13.5% of the variability of insulin resistance in our nonobese Japanese type 2 diabetic patients.
CONCLUSIONS: These results indicate that 1) nonobese Japanese type 2 diabetic patients with insulin resistance are characterized by high RLP cholesterol and triglyceride levels, and low HDL cholesterol levels; and 2) the level of serum triglycerides is an independent predictor of insulin resistance in these patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11128349     DOI: 10.2337/diacare.23.12.1766

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  15 in total

1.  Effects of insulin resistance on white matter microstructure in middle-aged and older adults.

Authors:  Seon Young Ryu; Jean-Philippe Coutu; H Diana Rosas; David H Salat
Journal:  Neurology       Date:  2014-04-25       Impact factor: 9.910

2.  Role of growth hormone, insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in development of non-alcoholic fatty liver disease.

Authors:  Tatsuki Ichikawa; Kazuhiko Nakao; Keisuke Hamasaki; Ryuji Furukawa; Shotarou Tsuruta; Yasuo Ueda; Naota Taura; Hidetaka Shibata; Masumi Fujimoto; Kan Toriyama; Katsumi Eguchi
Journal:  Hepatol Int       Date:  2007-06-01       Impact factor: 6.047

3.  Remnant cholesterol for the detection of glucose metabolic states in patients with coronary heart disease angina pectoris.

Authors:  Yang Wang; Yijia Liu; Rongrong Yang; Zhu Li; Jinyu Su; Tong Yang; Mei Ma; Guangwei Pan; Xianliang Wang; Lin Li; Chunquan Yu
Journal:  Acta Diabetol       Date:  2022-07-23       Impact factor: 4.087

4.  Insulin acutely inhibits intestinal lipoprotein secretion in humans in part by suppressing plasma free fatty acids.

Authors:  Mirjana Pavlic; Changting Xiao; Linda Szeto; Bruce W Patterson; Gary F Lewis
Journal:  Diabetes       Date:  2009-12-22       Impact factor: 9.461

5.  Both intestinal and hepatic lipoprotein production are stimulated by an acute elevation of plasma free fatty acids in humans.

Authors:  Hélène Duez; Benoît Lamarche; René Valéro; Mirjana Pavlic; Spencer Proctor; Changting Xiao; Linda Szeto; Bruce W Patterson; Gary F Lewis
Journal:  Circulation       Date:  2008-04-28       Impact factor: 29.690

6.  High remnant lipoprotein levels in patients with variant angina.

Authors:  Kunihisa Miwa; Toshinori Makita; Katsuhisa Ishii; Nobuaki Okuda; Ataru Taniguchi
Journal:  Clin Cardiol       Date:  2004-06       Impact factor: 2.882

7.  Effects of acute hyperglucagonemia on hepatic and intestinal lipoprotein production and clearance in healthy humans.

Authors:  Changting Xiao; Mirjana Pavlic; Linda Szeto; Bruce W Patterson; Gary F Lewis
Journal:  Diabetes       Date:  2010-10-27       Impact factor: 9.461

8.  Insulin Secretory Defect and Insulin Resistance in Isolated Impaired Fasting Glucose and Isolated Impaired Glucose Tolerance.

Authors:  Sae Aoyama-Sasabe; Mitsuo Fukushima; Xin Xin; Ataru Taniguchi; Yoshikatsu Nakai; Rie Mitsui; Yoshitaka Takahashi; Hideaki Tsuji; Daisuke Yabe; Koichiro Yasuda; Takeshi Kurose; Nobuya Inagaki; Yutaka Seino
Journal:  J Diabetes Res       Date:  2015-12-15       Impact factor: 4.011

9.  Insulin secretory capacity and insulin sensitivity in impaired fasting glucose in Japanese.

Authors:  Rie Mitsui; Mitsuo Fukushima; Ataru Taniguchi; Yoshikatsu Nakai; Sae Aoyama; Yoshitaka Takahashi; Hideaki Tsuji; Daisuke Yabe; Koichiro Yasuda; Takeshi Kurose; Toshiko Kawakita; Yutaka Seino; Nobuya Inagaki
Journal:  J Diabetes Investig       Date:  2012-08-20       Impact factor: 4.232

10.  Insulin sensitivity and Lp(alpha) concentrations in normoglycemic offspring of type 2 diabetic parents.

Authors:  Agathoklis Psyrogiannis; Ioannis Habeos; Venetsana Kyriazopoulou
Journal:  Lipids Health Dis       Date:  2003-10-29       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.